Medigen Vaccine Biologics Corp. is partnering with an American biotech company to develop a COVID-19 vaccine patch, which could begin human clinical trials as early as in 2022, the Taiwanese vaccine maker announced Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
- Politics
KMT denies tension after TPP's Huang joins New Taipei mayor race
12/28/2025 08:02 PM - Society
Snow-chasing rider fined for bringing horse onto Wuling highway
12/28/2025 07:19 PM - Politics
Ministry faulted for delayed response to starfish outbreak on Dongsha
12/28/2025 04:47 PM - Cross-Strait
Taipei mayor calls for 'peace and prosperity' at Shanghai forum
12/28/2025 04:04 PM